Showcase to benefit Irish engineers
The Enterprise Ireland event, which welcomed 50 European buyers from the world’s leading pharmaceutical and biotechnology companies to Dublin, yesterday, showcased the best in Irish pharmaceutical and biotech plant design, construction and engineering.
The importance and potential of the event is real given that in the past two years, Irish companies have secured construction contracts on four facilities in Germany, Switzerland, France and Belgium worth a combined value of more than €80 million and that another €160 billion is expected to be invested in plant construction over the next three years.





